The treatment of Asthma & Hypoglycemia with vitamins

Asthma and Hypoglycemia: Mitamins custom make quality formulas for the treatment of Asthma & Hypoglycemia with vitamins. A Asthma & Hypoglycemia formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Asthma and Hypoglycemia

  • Amount Per Serving
    % DV
    Vitamin A
    2500
    IU
    50%
    Vitamin C
    100
    mg
    167%
    Thiamin
    25
    mg
    1667%
    Riboflavin
    25
    mg
    1471%
    Niacin
    50
    mg
    250%
    Vitamin B6
    25
    mg
    1250%
    Folate
    200
    mcg
    50%
    Vitamin B12
    25
    mcg
    417%
    Biotin
    25
    mcg
    8%
    Pantothenic Acid
    25
    mg
    250%
    Magnesium
    50
    mg
    13%
  • Amount Per Serving
    % DV
    Chromium
    100
    mcg
    83%
    Choline Bitartrate
    25
    mg
    *
    Inositol
    25
    mg
    *
    PABA
    25
    mg
    *
    MSM
    100
    mg
    *
    Bioflavonoid Concentrate
    50
    mg
    *
    American Ginseng Extract
    50
    mg
    *
    Licorice Extract
    50
    mg
    *
    Ginger Extract
    50
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice

Asthma and Hypoglycemia Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Development Of Effective, Novel Treatments Critical To Ensure Growth In The European Bladder Cancer Therapeutics Market
None of the developments in the bladder cancer area have improved the long-term survival rate of patients, with research results also remaining disappointing. Patients still die from muscle invasive disease, despite aggressive therapy with curative intent. Median survival after chemotherapy is usually 14 months. Moreover, no new drugs have entered the market over the past two decades, encouraging the scope for newer and more effective bladder cancer therapeutics.
GSK Submits Cervarix? Licence Application To Japan's Health Authorities
GlaxoSmithKline (GSK) announced that it has submitted a licence application for its cervical cancer candidate vaccine Cervarix? to the Japanese Ministry of Health, Labor and Welfare (MHLW). This is the first vaccine for the prevention of cervical cancer to be filed for approval in Japan.GSK's cervical cancer candidate vaccine is formulated with a novel proprietary adjuvant system called AS04, intended to enhance immune response and increase duration of protection.
This information concerning the support of Asthma and Hypoglycemia treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments